Synageva BioPharma Corp $72.17

up +0.05


29/8/2014 04:00 PM  |  NASDAQ : GEVA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get GEVA Trend Analysis - it has outperformed the S&P 500 by 31%

Partner Headlines

  1. Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's 75% Gain ...

    Benzinga
  2. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  3. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; GoPro Shares ...

    Benzinga
  4. Markets Surge; GM June Sales Rise 1%

    Benzinga
  5. Morning Market Losers

    Benzinga
  6. SYNAGEVA BIOPHARMA

    IBD
  7. Synageva BioPharma Reports Phase 3 Study Meets Primary Endpoint And Six ...

    Benzinga
  8. UPDATE: Morgan Stanley Reiterates on Synageva BioPharma as Brain-Blood ...

    Benzinga
  9. UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public Offering ...

    Benzinga
  10. Synageva BioPharma Completes Target Enrollment in Phase 3 ARISE Trial

    Benzinga
  11. Benzinga's Top Initiations

    Benzinga
  12. UPDATE: Goldman Sachs initiates on Synageva Following Positive Phase II ...

    Benzinga
  13. UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on Lack of NT ...

    Benzinga
  14. UPDATE: Wedbush Downgrades Synageva BioPharma on Valuation

    Benzinga
  15. Benzinga's Volume Movers

    Benzinga
  16. Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share

    Benzinga
  17. Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 Shares

    GuruFocus
  18. UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Synageva ...

    Benzinga
  19. Synageva Prices 2.15M Share Public Offering at $47.53/Share

    Benzinga
  20. UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack of Near-Term ...

    Benzinga
  21. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 60,0 ...

    GuruFocus
  22. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 35,0 ...

    GuruFocus
  23. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 35,0 ...

    GuruFocus
  24. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises PT on Synageva ...

    Benzinga
  25. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  26. Benzinga's Top Initiations

    Benzinga
  27. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 70,0 ...

    GuruFocus
  28. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 70,0 ...

    GuruFocus
  29. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  30. Synageva BioPharma Corp. (GEVA) SVP, CFO Carsten Boess sells 6,618 Shares

    GuruFocus
  31. Merck &, Quest Diagnostics Among Stocks Setting 52-Week Highs Thursday

    FoxBusiness
  32. Synageva BioPharma, WesBanco Hit 52-week Highs Wednesday

    FoxBusiness
  33. Synageva BioPharma, Deltek Hit 52-week Highs Tuesday

    FoxBusiness
  34. ASML, Wolverine World Wide Included in Stocks Up on High Volume Tuesday

    FoxBusiness
  35. Synageva BioPharma Announces $80 Million Proposed Public Offering of Common ...

    Benzinga
  36. Four Winning Trades Based on Analyst Calls

    Benzinga
  37. CF Industries Holdings, SBA Communications Corporation Included in Stocks ...

    FoxBusiness
  38. Winning Trades Based on Analyst Ratings for June 25

    Benzinga
  39. Synageva BioPharma Jumps on Canaccord Genuity Initiation

    Benzinga
  40. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness
  41. UPDATE: Canaccord Genuity Initiates Synageva BioPharma at BUy, $60 PT; ...

    Benzinga
  42. Synageva BioPharma Corp. (GEVA) President & CEO Sanj K Patel sells 50, ...

    GuruFocus
  43. Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal Disease ...

    Benzinga
Trading Center